Robl J M, Kasinathan P, Sullivan E, Kuroiwa Y, Tomizuka K, Ishida I
Hematech, LLC, 4401 South Technology Drive, Sioux Falls, SD 57106, USA.
Theriogenology. 2003 Jan 1;59(1):107-13. doi: 10.1016/s0093-691x(02)01262-1.
Artificial chromosome vectors are autonomous, replicating DNA sequences containing a centromere, two telomeres and origins of replication. Artificial chromosomes have been proposed as possible vectors for transferring very large sequences of DNA into animals. Our goal has been to insert the entire human heavy- and light-chain immunoglobulin loci into cattle as a step in developing a production system for large quantities of human therapeutic polyclonal antibodies. A mitotically stable fragment of chromosome 14, containing the human heavy-chain locus, was identified. A chromosome cloning system was used to transfer the human lambda locus from an unstable chromosome 22 fragment to the chromosome 14 fragment to create a human artificial chromosome (HAC) carrying both immunoglobulin loci. The HAC vector was introduced into bovine primary fibroblasts. Selected fibroblast clones were rejuvenated and expanded by producing cloned fetuses. Cloned fetal cells were selected and recloned to produce 21 healthy, transchromosomic (Tc) calves. Four were analyzed and shown to functionally rearrange both heavy- and light-chain human immunoglobulin loci and produce human polyclonal antibodies. These results demonstrate the feasibility of using HAC vectors for production of transgenic livestock. More importantly, Tc cattle containing human immunoglobulin genes may be used to produce novel human polyclonal therapeutics.
人工染色体载体是自主复制的DNA序列,包含一个着丝粒、两个端粒和复制起点。人工染色体已被提议作为将非常大的DNA序列导入动物的可能载体。我们的目标是将整个人类重链和轻链免疫球蛋白基因座插入牛体内,作为开发大量生产人类治疗性多克隆抗体的生产系统的一个步骤。鉴定出了14号染色体上一个有丝分裂稳定的片段,其中包含人类重链基因座。利用染色体克隆系统将人类λ基因座从22号染色体的一个不稳定片段转移到14号染色体片段上,从而创建了一个携带两个免疫球蛋白基因座的人类人工染色体(HAC)。将HAC载体导入牛原代成纤维细胞。通过产生克隆胎儿使选定的成纤维细胞克隆恢复活力并进行扩增。选择克隆胎儿细胞并再次克隆,以产生21头健康的转染色体(Tc)牛。对其中4头牛进行分析,结果表明它们的人类重链和轻链免疫球蛋白基因座都发生了功能性重排,并产生了人类多克隆抗体。这些结果证明了使用HAC载体生产转基因家畜的可行性。更重要的是,含有人类免疫球蛋白基因的Tc牛可用于生产新型人类多克隆治疗药物。